
Sign up to save your podcasts
Or


As the U.S. Food and Drug Administration prepares to issue a decision on the handling of chemical abortion safeguards, the author of a new study is sounding the alarm over reported dangers posed by the abortion pill.
Dr. James Studnicki, vice president of data analytics at the The Charlotte Lozier Institute, said these pills present a potential public health crisis, especially as the FDA weighs whether to continue requiring women to receive these pills in person.
Go inside the debate on this episode of "Edifi With Billy Hallowell."
By Washington Times / Billy Hallowell4.9
3737 ratings
As the U.S. Food and Drug Administration prepares to issue a decision on the handling of chemical abortion safeguards, the author of a new study is sounding the alarm over reported dangers posed by the abortion pill.
Dr. James Studnicki, vice president of data analytics at the The Charlotte Lozier Institute, said these pills present a potential public health crisis, especially as the FDA weighs whether to continue requiring women to receive these pills in person.
Go inside the debate on this episode of "Edifi With Billy Hallowell."

8,627 Listeners

154,177 Listeners

7,088 Listeners

21,066 Listeners

28,378 Listeners

68,433 Listeners

1,136 Listeners

5,114 Listeners

40,430 Listeners

185 Listeners

189 Listeners

26,641 Listeners

1,092 Listeners

402 Listeners

283 Listeners